Australia's Cyclopharm soars on diagnostic tech deployment contract

Cyclopharm

23/01/2025 24:45

** Shares of Cyclopharm  CYC.AX  up 17.2% at A$2.38
    ** Stock rises as much as 23.2% to A$2.5 in early trade,
hitting its highest level since Oct 16, 2023
    ** Radiopharmaceutical firm signs contract with healthcare
provider Hospital Corporation of America Healthcare (HCA)
    ** Says contract for deployment of co's Technegas imaging
technology in up to 169 nuclear medicine departments across
HCA'S network
    ** Co did not provide any transactional details regarding
contract
    ** Technegas imaging technology is used to detect pulmonary
embolism
    ** More than 502,000 shares change hands, 5.8 times the
30-day avg
    ** Cyclopahrm up 49.5% YTD, including current session's
moves

 (Reporting by Nikita Maria Jino in Bengaluru)
 ((Nikita.Jino@thomsonreuters.com;))